Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9274390 | 0.99 | AGTR1 (0.65) | AGTR1AGTR2 | |
| SCHEMBL9272086 | 0.98 | AGTR1 (0.68) | AGTR1AGTR2 | |
| SCHEMBL9277167 | 0.96 | AGTR1 (0.62) | AGTR1AGTR2 | |
| SCHEMBL9270976 | 0.95 | AGTR1 (0.64) | AGTR1AGTR2 | |
| SCHEMBL9202162 | 0.94 | AGTR1 (0.72) | AGTR1AGTR2 | |
| Sc-55634 SCHEMBL9202651 | 0.93 | AGTR1 (0.76) | AGTR1AGTR2 | |
| SCHEMBL9277161 | 0.93 | AGTR1 (0.62) | AGTR1AGTR2 | |
| SCHEMBL9275056 | 0.92 | AGTR1 (0.60) | AGTR1AGTR2 | |
| SCHEMBL7675463 | 0.92 | AGTR1 (0.63) | AGTR1AGTR2 | |
| SCHEMBL9271314 | 0.92 | AGTR1 (0.59) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0664803-A1 | N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1995-08-02 | — | — | EP | claimed |
| WO-1994008989-A1 | N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1994-04-28 | — | — | WO | claimed |
| EP-0664803-A1 | N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994008989-A1 | N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1994-04-28 | — | — | WO | disclosed |